Background Paths
Background Paths
About Us

About BoloBridge

A speech wellness and education platform for children ages 3 to 12, grounded in ASHA developmental norms and peer-reviewed research in pediatric speech-language pathology.

0

Languages Supported

0+

Research Sources

0

Phonemes Screened

0

Learning Modules

What is BoloBridge?

BoloBridge is a speech wellness platform for children ages 3 through 12. Its flagship features, a structured speech screening tool and a conversational therapy game (Story Studio), bring triage-level assessment and evidence-based intervention to communities that lack access to speech-language pathologists.

The screening uses ASHA developmental norms to test age-appropriate sounds, run dynamic stimulability probes, and generate personalized risk reports. Story Studio applies the recasting technique (Fan et al., 2025) through conversational role-play, naturally modeling correct speech forms without direct correction. Combined with structured learning modules and daily practice challenges, BoloBridge provides consistent, accessible speech practice grounded in clinical methodology.

Founder & Lead Dev

About the Developer

BoloBridge was developed by Utkarsh Tannan at the University of Pennsylvania, where he is completing a B.A. in Neuroscience and an accelerated M.S. in Bioengineering (GPA: 3.93), with minors in Health Care Management (Wharton) and Chemistry.

Utkarsh's research spans speech production, infant language acquisition, and clinical neuroscience. At Penn's Infant Language Center (PI: Dr. Daniel Swingley), he automated phoneme transcription pipelines and identified systematic detection failures in gaze-tracking tools affecting 25% of participants. At Boston University's Guenther Lab (PI: Dr. Frank Guenther), he designed speech-motor learning experiments across 350+ participants. He also co-authored a publication in Otology & Neurotology evaluating speech-to-text clinical usability across 29 applications and 140 languages. His clinical experience includes 1,200+ diagnostic neurological procedures and patient navigation for Spanish-speaking families at Puentes de Salud. BoloBridge grew from this intersection of research, clinical exposure, and a commitment to addressing global disparities in pediatric speech-language pathology.

Neuroscience (B.A.)Bioengineering (M.S.)Speech-Motor LearningInfant Language AcquisitionClinical DiagnosticsHealth Care Mgmt (Wharton)Python / MATLABNext.js / TypeScript

Our Mission

Reducing barriers to early speech screening and structured practice for children worldwide, particularly in underserved and multilingual communities where access to speech-language pathologists remains limited.

Accessible

Designed for low-bandwidth environments and multilingual families, particularly in communities with limited access to speech-language pathology services.

Inclusive

Supporting 6 languages including English, Spanish, Hindi, Afrikaans, Bengali, and Tagalog with culturally relevant content for diverse communities worldwide.

Empowering

Giving families the tools for structured home practice with evidence-based techniques, while encouraging professional consultation when needed.

Bibliography

Research & Sources

Our content is informed by established guidelines and peer-reviewed research in speech-language development. Below are the primary sources referenced. README on GitHub.

ASHA: Speech Sound Disorders

ASHA: Spoken Language Disorders

ASHA: Late Language Emergence

WHO: Early Childhood Development

McLeod & Crowe (2018) -Speech Sound Acquisition

Law et al. (2017) -Speech & Language Therapy Interventions

Wren et al. (2016) -Prevalence of Speech Sound Disorders

Gillon (2004) -Phonological Awareness

Broomfield & Dodd (2004) -Classification of Speech Disorders

Eadie et al. (2015) -Speech Sound Disorder at 4 Years

Unicef: Early Childhood Development

NIH/NIDCD: Speech & Language Developmental Milestones

Benway & Preston (2024) -AI-Assisted Speech Therapy

Kalia et al. (2025) -Vocal Biomarker Development

Fan et al. (2025) -Recasting in Speech Therapy

Unicomb et al. (2020) -Cycles Approach Efficacy

Gross & Dube (2025) -Socio-Affective Digital Therapeutics

Important Disclaimer

BoloBridge is a general wellness and educational application. It is not a medical device, and it does not diagnose, treat, cure, mitigate, or prevent any disease or condition. BoloBridge is not a substitute for professional speech-language pathology services.

If you have concerns about your child's speech or language development, please consult a licensed speech-language pathologist or your pediatrician.

Content is informed by published research and ASHA developmental norms, but has not been clinically validated as a treatment. The screening tool provides triage-level assessment only and should not replace professional evaluation.

Contact

Questions, feedback, or collaboration inquiries are welcome.

Email

utannan@gmail.com

Location

Philadelphia, PA

Feedback

feedback@bolobridge.com